Cascade Pharmaceuticals, Inc
Cascade Pharmaceuticals, Inc
Explore linked clinical trials.6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of CS060380 Tablets in Patients With MASH and Obesity | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Phase 2 | 2026-08-10 | NCT07466017 | |
| A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitis | Recruiting | Phase 3 | 2026-07-08 | NCT07282353 | |
| Trial of CS060380 Tablets for Non-alcoholic Steatohepatitis (NASH) | metabolic dysfunction-associated steatohepatitis | Recruiting | Phase 2 | 2026-03-13 | NCT07198386 | |
| Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060304 in Healthy and Elevated LDL-C Subjects | metabolic dysfunction-associated steatohepatitis | Active, not recruiting | Phase 1 | 2026-03-13 | NCT06485245 | |
| CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis) | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, primary sclerosing cholangitis | Active, not recruiting | Phase 2 | 2026-03-13 | NCT05896137 | |
| CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis) | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitis | Active, not recruiting | Phase 2 | 2026-03-13 | NCT05896124 |